ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1948

A Dual Role for IFN-γ in Development of Peripheral B Cells in Lupus-Prone MRL/Lpr Mice

Takeshi Machida1, Natsumi Sakamoto1, Gary S. Gilkeson2 and Hideharu Sekine1, 1Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan, 2Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: B cells, SLE and animal models

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Biology and Targets in Autoimmune Disease: Systemic Lupus Erythematosus and Related Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: It had been reported previously that IFN-gamma and IFN-gamma-receptor-1 (IFNGR1) were required for auto-Ab production and development of renal disease in lupus-prone MRL/lpr mice. At ACR 2011, we reported that MRL/lpr mice deficient for the transcription factor IFN regulatory factor-4 (IRF-4), that is required for Th2/Th17 differentiation, developed granulomas in multiple organs with significantly increased numbers of IFN-gamma-producing CD4+ T cells (Th1 cells) and high serum IFN-gamma levels after 12 weeks of age (Fig. 1A). Strikingly, unlike their WT littermates, they also exhibited total loss of splenic CD19+IgM+ B cells by 12 weeks of age. Similar B cell loss was observed in Irf4-/- MRL+/+ mice but not in Irf4-/- C57BL/6 mice, suggesting a role for IFN-gamma in survival of peripheral B cells in mice with an MRL background. This study aimed to further define roles for IFN-gamma in survival of peripheral B cells and in development of autoreactive B cells in MRL/lpr mice.

Methods: Irf4/Ifng or Irf4/Ifngr1 double-gene knockout MRL/lpr mice were generated by backcrossing with C57BL/6 mice lacking corresponding genes for 8 generations. Expression levels of CD19, IgM, CD21, CD23, and IFNGR1 on splenic B cells were analyzed by flow. Splenic follicular (FO)- and marginal zone (MZ)-B cells were isolated by cell sorting and frequency of anti-dsDNA Ab-secreting cells was quantified by ELISPOT assay.

Results: The splenic B cell loss observed in Irf4-/- MRL/lpr mice was restored in Irf4-/-Ifng-/- and Irf4-/-Ifngr1-/- MRL/lpr mice even after 12 weeks of age (Fig. 1B).

�à–¾: Macintosh HD:Users:machidatakeshi:Desktop:Fig1(140624).png
CD21hiCD23lo MZ-B cells of WT MRL/lpr and MRL+/+ mice showed high IFNGR1 expression levels compared to their CD21loCD23hi FO-B cells. In contrast, MZ- and FO-B cells of C57BL/6 mice showed minimal IFNGR1 expression (Fig. 2A). MZ-B cells of MRL/lpr mice showed significantly increased frequency of anti-dsDNA IgM-secreting cells compared to their FO-B cells or MZ/FO-B cells of C57BL/6 mice (Fig. 2B).

�à–¾: Macintosh HD:Users:machidatakeshi:Desktop:Fig2(140624).png
Conclusion: Our results suggest a dual role for IFN-gamma in peripheral B-cell development in murine lupus: expression of IFNGR1 on splenic B cells, especially on MZ-B cells, is required for development of autoreactive B cells whereas high levels of serum IFN-gamma impact on their survival.


Disclosure:

T. Machida,
None;

N. Sakamoto,
None;

G. S. Gilkeson,
None;

H. Sekine,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-dual-role-for-ifn-%ce%b3-in-development-of-peripheral-b-cells-in-lupus-prone-mrllpr-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology